LLM-Generated Medical Summaries During Hospitalization to Improve Patient Activation in High-Risk Pregnancies

Condition(s) studied

Investigational drug(s) / intervention(s)

LLM-Generated Medical Summaries: Participants receive patient-facing written medical summaries generated by a large language model (LLM) using a secure, privacy-protected AI environment at Sheba Medical Center. The intervention is informational and does not involve administration of a drug, use of a medical device, or performance of a medical procedure. Each summary is reviewed by a physician for medical accuracy before being provided to the participant. If a summary is deemed inadequate, it may be corrected by the reviewing physician before delivery or rejected and not provided. The first summary is generated on days 3-5 of hospitalization, with updated summaries every 3-5 days and a maximum of 3 summaries per participant.

Study summary

The goal of this clinical trial is to learn if AI-generated medical summaries help hospitalized pregnant participants better understand and actively participate in their own care. The main questions it aims to answer are:

Do AI-generated summaries increase participant activation (knowledge, skills, and confidence in managing their health)? How accurate are the AI-generated summaries, as assessed by physicians? Do AI-generated summaries affect depressive symptoms during hospitalization?

Researchers will compare participants who receive periodic AI-generated summaries of their medical care with participants who receive standard care to determine whether the summaries improve patient activation during hospitalization.

Participants will:

Be randomly assigned to receive AI-generated medical summaries or standard care.

Complete the Patient Activation Measure (PAM-13) at baseline before the intervention and again after the intervention.

Complete the Edinburgh Postnatal Depression Scale (EPDS) at baseline and again after the intervention.

Receive up to 3 summaries during their hospitalization (intervention group only).

Eligibility

Primary outcome measure(s)

• Change in Patient Activation Measure Score — From baseline (pre-intervention) to post-intervention during hospitalization, approximately 1-8 weeks.
  Change in Patient Activation Measure (PAM-13) score from baseline (pre-intervention) to post-intervention, compared between the intervention and control groups. The PAM-13 is a 13-item instrument assessing patient knowledge, skills, and confidence in managing their own health. Scores range from 0 to 100, with higher scores indicating greater patient activation.
• Number of LLM-Generated Medical Summaries Requiring Physician Modification or Rejection — Throughout hospitalization, approximately 1-8 weeks
  Number of LLM-generated medical summaries that require physician modification or are rejected following physician review and prior to delivery to the participant.

Trial sites (1)

More Sheba Medical Center trials in Israel

Other trials for the same condition